Vaccine Price Changes

Sanofi Pasteur and Merck recently announced updated catalog pricing on many of their vaccines.  Please note that due to CPP’s contract negotiations with these vendors, CPP members can continue to purchase vaccines at the pre-increase price until the following:

Sanofi Pasteur:  1/1/2019 implementation date

Merck:  2/13/2019 implementation date

Also effective 1/1/2019, Sanofi Pasteur is eliminating the $25 service fee currently assessed on non-influenza vaccine shipments less than $600.  The policy change is a direct result of our strong partnership with Sanofi Pasteur and feedback from you.  They’ve made this change to better meet your needs.

For updated member pricing sheets, please contact the CPP office.

CPP Partners with Dynavax!

CPP is pleased to announce a new partnership with Dynavax, the manufacturer of the newly approved adult hepatitis-B vaccine Heplisav-B® administered as a 2-dose series. (April 2018 MMWR publication of the ACIP recommendation)

Members of CPP who opt-into the Dynavax contract can access discounted pricing on doses of Heplisav-B® purchased through an authorized distributor. For a complete list of authorized distributors, see attached list or call 1-84-HEPLISAV (1-844-375-4728).

Members who are interested in participating in the CPP/Dynavax contract should contact the CPP office at 614-722-2145 or cpp@nationwidechildrens.org to obtain an opt-in form.

If you have any questions, please don’t hesitate to contact us!

Vaccine Confidence Webinar Now Available On-Demand

Sanofi Pasteur hosted a webinar in April entitled Vaccine Confidence: The Key to Communicating with Parents and Patients.  A recording of the webinar, which was attended by over 600 medical professionals, is now available to you on-demand.  Speakers include Gary S. Marshall, MD from the University of Louisville School of Medicine and Carole H. Moloney, RN, MSN, CPNP from Boston Medical Center.

Simply go to http://vacadvwebcast2017.prihcs.com to register.

AAP Publishes Advice for Upcoming Flu Vaccination Season

For the upcoming 2018-2019 flu vaccination season, the American Academy of Pediatrics is advising parents to choose the flu shot.

In  February 2018, ACIP decided to make LAIV4 available for the 2018-2019 flu season, based on indirect study data from the manufacturer suggesting their new formulation would be effective, as well as a review of other published research.

However, upon review of the same data, the AAP recommends children receive the injectable form of the vaccine, which was shown to be more consistently effective against most strains of the flu virus over the past several flu seasons. For those children who would otherwise receive no flu vaccine, the AAP says the nasal spray vaccine can be given as a last resort, though it could leave them at higher risk for flu than if they had received the flu shot.

AAP will publish its formal policy statement on flu prevention and treatment in September.

Full Article